Career Center

SoMCC Event



Industry Insights - BioPharmaceuticals Coming of Age - A Drug Development Perspective from Genentech

Date:   Wednesday, January 19, 2011

Time:   12:00 -1:00 PM (Presentation and Q&A)
1:00-1:30 PM (Informal reception)

Location:   LK130, Li Ka Shing Center

Sponsor:   School of Medicine Career Center (SoMCC)

Event details:  

Biopharmaceuticals/Biologics are a large part of the new therapeutics being developed worldwide.  The total market capitalization for the biotech industry in the US alone is projected to exceed $350 billion (US) again this year, and R&D investment in biopharmaceuticals have led to great advances in basic and applied research.  In this program Drs. Joshi and Song will introduce some of the drug development work done at Genentech on Biopharmaceuticals, including an introduction to Monoclonal Antibodies as well as a portrayal of past successes with RituxanÒ and LucentisÒ.  Future advances will be portrayed by examples from the development of antibody drug conjugate –T-DM1, and targeted therapeutics, personalized medicine, and the promise these present will be explored.

Dr Joshi will also provide a brief introduction to the American Association of Pharmaceutical Scientists (AAPS), a professional, scientific society of more than 12,000 members employed in academia, industry, government and other research institutes worldwide.  AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance contributions to public health, and to support on-going education, opportunities for networking, and professional development.  They engage with the scientific community in several venues, through conferences, seminars and forums – such as this one – for those interested in career opportunities in Biopharmaceuticals.  *(Please also note: the National Biotechnology Conference – sponsored by AAPS – will be held from May 16-18 in San Francisco.  This conference is devoted to Biopharmaceuticals, and program info can be found

About Our Presenters:        
An Song, Ph.D.
Sr. Scientist, Associate Director of BioAnalytical Research & Development, Genentech Research and Early Development 
Dr. Song received her Ph.D. from Indiana U. in 1996, and was a Postdoctoral Fellow in the Department of Pediatrics-immunology and Transplantation Biology at Stanford 1996-2000.  Upon completion of postdoctoral work she was hired as a Research Assistant Professor and faculty of the Immunology Program.  She later joined Genentech, where she is now head of the BARD group responsible for developing pharmacokinetics, pharmacodynamics, anti-therapeutic antibody (ATA), predictive biomarkers, and biological characterization assays to the product development pipeline from early development through post-marketing.  Dr. Song is active as a member of AAPS and preparing industry white papers.
Amita Joshi, Ph.D.
Sr Scientist/Sr Director , Head of Clinical Pharmacology, Genentech Research and Early Development
Dr Joshi received her Ph.D. from the U. Texas at Austin in 1990.  She was a Clinical Pharmacokineticist at DuPont /DuPont-Merck Pharmaceuticals from 1991-2000.  She joined Genentech in 2000 and is currently Senior Director and Head, Clinical Pharmacology and Modeling and Simulation (M&S). She has worked in the area of Clinical Pharmacology for the past 20 years.  Her interests are in the area of applying principles of translational pharmacology and the M&S toolbox for the development of Therapeutic Proteins and Small Molecules.  She has also served in various capacities on AAPS committees, and sits on several Industry/Academia/Regulatory cross-functional task forces on Clinical Pharmacology. Amita is also Adjunct Professor of Pharmaceutical Sciences at U. of Tennessee at Memphis.

Free and open to Stanford ID holders.
Additional information and/or registration:   RSVP required. Space is limited, register online

Footer Links: